Literature DB >> 7591631

Recovery of lens optics and epithelial enzymes after ultraviolet A radiation.

A Dovrat1, O Weinreb.   

Abstract

PURPOSE: To establish the mechanism by which ultraviolet A (UVA) radiation causes irreversible damage to the eye lens.
METHODS: The authors irradiated 223 bovine lenses in organ culture with 22.4, 33.6, and 44.8 J/cm2 of UVA radiation (365 nm) and studied biochemical and optical properties of the lenses in long-term culture conditions. Each lens tested was placed in a specially designed cell. The lenses were oriented so that the anterior surface faced the incident UVA radiation source, and they were maintained in their cells during irradiation. After irradiation, lens optical quality was monitored throughout the culture period, and lens samples were taken for enzyme analysis.
RESULTS: Full recovery of lens optical damage and activity of the enzymes hexokinase, catalase, and glucose-6-phosphate dehydrogenase in lens epithelium was observed after 8 days in culture after irradiation with 22.4J/cm2. After irradiation with 33.6J/cm2, partial recovery of optical damage was found, and there was between 80% to 90% recovery of the enzyme activity. No recovery of optical and enzyme activity was found after 44.8J/cm2 irradiation.
CONCLUSIONS: Irradiation between 22.4J/cm2 to 33.6J/cm2 of UVA at 365 nm is the minimal level of irradiation that causes irreversible damage to lens enzymes and optics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591631

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  The concentration of light in the human lens.

Authors:  J C Merriam
Journal:  Trans Am Ophthalmol Soc       Date:  1996

2.  Increased expression of osteonectin/SPARC mRNA and protein in age-related human cataracts and spatial expression in the normal human lens.

Authors:  M Kantorow; Q Huang; X J Yang; E H Sage; K S Magabo; K M Miller; J Horwitz
Journal:  Mol Vis       Date:  2000-04-05       Impact factor: 2.367

3.  Featured Article: Inhibition of diabetic cataract by glucose tolerance factor extracted from yeast.

Authors:  Nitsa Mirsky; Revital Cohen; Anat Eliaz; Ahuva Dovrat
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

4.  The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.

Authors:  Orit Bar-Am; Orly Weinreb; Tamar Amit; Moussa B H Youdim
Journal:  J Mol Neurosci       Date:  2008-08-27       Impact factor: 2.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.